Biopharma Daily Stock Updates - 01/26/21

$XBI $154.38 (-1.76%) 📉


COVID:

$MRNA (+3.30%) - Moderna Provides U.S. COVID-19 Vaccine Supply Update


PIPELINE:

$AMRN (-1.06%) - AMARIN EXPANDS CARDIOVASCULAR RISK REDUCTION PATENT INFRINGEMENT LAWSUIT TO INCLUDE HEALTH CARE INSURANCE PROVIDER


$AGIOS (-2.95%) - Agios Announces Phase 3 ACTIVATE-T Trial of Mitapivat Achieved Primary Endpoint in Adults with Pyruvate Kinase Deficiency Who Are Regularly Transfused


$CRDF (+1.55%) - Cardiff Oncology Receives "Study May Proceed" from FDA to Initiate Phase 2 Trial of Onvansertib in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)


$AZN (+0.80%) - Symbicort Turbuhaler approved in China as an anti-inflammatory reliever in mild asthma


$ADMA (-0.40%) - ADMA Biologics Receives Unique Permanent J-Code for ASCENIV™


$BCYC (-0.56%) - Bicycle Therapeutics Announces Publication of Article Highlighting Preclinical Data of Tumor-Targeted Immune Cell Agonists (TICAs™) in the Journal for ImmunoTherapy of Cancer


$RYTM (-13.17%) - Rhythm Pharmaceuticals Announces Positive Data with Setmelanotide in Additional MC4R Pathway Deficiency-related Obesities


$MYOV (+9.32%) & $PFE (+0.13%) - Myovant Sciences and Pfizer Announce Positive One-Year Data from Phase 3 SPIRIT Extension Study of Once-Daily Relugolix Combination Therapy in Women with Endometriosis


$ELOX (-4.33%) - Eloxx Announces Publication of Scientific Manuscript on ELX-02 in the Journal of Clinical Pharmacology in Drug Development


$AGEN (-5.00%) - Agenus Enters into Clinical Collaboration with Nelum for Zalifrelimab Combination


FINANCIAL:


$CBIO (-7.32%) - Catalyst Biosciences Announces Proposed Public Offering of Common Stock


$PGEN (-8.60%) - Precigen Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares


0 comments

*Disclaimer: Information provided on bpiq.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Big Movers™ is a trademark of Amp Biotech Research, LLC

©2021 by Biopharm IQ. Website by Awaken Studio.

SITE